Reply to Martin et al.: Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy!
- PMID: 35358029
- PMCID: PMC9873113
- DOI: 10.1164/rccm.202201-0042LE
Reply to Martin et al.: Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy!
Comment on
-
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.Am J Respir Crit Care Med. 2022 Mar 1;205(5):529-539. doi: 10.1164/rccm.202108-1986OC. Am J Respir Crit Care Med. 2022. PMID: 34784492 Free PMC article.
-
Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy!Am J Respir Crit Care Med. 2022 Jun 1;205(11):1365-1366. doi: 10.1164/rccm.202112-2852LE. Am J Respir Crit Care Med. 2022. PMID: 35358030 Free PMC article. No abstract available.
References
-
- Hayes D, Jr, Long FR, McCoy KS, Sheikh SI. Improvement in bronchiectasis on CT imaging in a pediatric patient with cystic fibrosis on ivacaftor therapy. Respiration . 2014;88:345. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources